Showing results (751-760 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|May 22, 2014
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI StudyL Pasina, C D Djade, M Tettamanti, et al.Journal of Clinical Pharmacy and Therapeutics|May 22, 2014
A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteersC Briciu, M Neag, D Muntean, et al.Journal of Clinical Pharmacy and Therapeutics|January 17, 2014
Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulationH-S Lim, Y P Chong, Y-H Noh, et al.Journal of Clinical Pharmacy and Therapeutics|January 11, 2014
Longitudinal monitoring of CYP3A activity in patients receiving 3 cycles of itraconazole pulse therapy for onychomycosisS Shibata, H Takahashi, N Ono, et al.Journal of Clinical Pharmacy and Therapeutics|October 13, 2012
Impact of biomarker usage on oncology drug developmentK Hayashi, S Masuda, H KimuraJournal of Clinical Pharmacy and Therapeutics|February 1, 1997
Therapeutic drug monitoring of gentamicin: a 6-year follow-up auditR Ismail, A H Haq, M Azman, et al.Journal of Clinical Pharmacy and Therapeutics|February 1, 1997
Hydrocortisone 17-butyrate degradation in the presence of micro-organismsS M Rabouan-Guyon, C M Fauvaud, P Y Courtois, et al.Journal of Clinical Pharmacy and Therapeutics|November 9, 2022
CytoSorb haemoadsorption for removal of apixaban-A proof-of-concept pilot case for a randomized controlled trialMarianna Buonocore, Steffen Rex, Karlien Degezelle, et al.Journal of Clinical Pharmacy and Therapeutics|August 7, 2022
Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patientsJan Miroslav Hartinger, Pavel Ryšánek, Ondřej Slanař, et al.Journal of Clinical Pharmacy and Therapeutics|September 20, 2021
Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta-analysis based on randomized controlled trialsQian Wu, Miaowen Liu, Zige Fang, et al.Pageof 325